+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Animal Vaccines Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5317900
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior animal health leaders are navigating a period of accelerated change across the animal vaccines market. A convergence of scientific advances, regulatory shifts, and dynamic commercial expectations demands strategic agility and the ability to convert innovation into regionally adaptable and commercially viable solutions.

Market Snapshot: Animal Vaccines Market Growth and Trends

The animal vaccines market expanded from USD 14.58 billion in 2025 to USD 15.53 billion in 2026, with an anticipated CAGR of 6.99%. Projections place the sector at USD 23.40 billion by 2032. This sustained growth is driven by ongoing innovations in molecular biology, rising investment in platform technologies, heightened focus on preventing zoonotic diseases, and evolving market demands resulting from the globalization of animal health. These trends underscore increasing complexity in product development and strategic emphasis on disease prevention, not only for livestock productivity but also for companion animal well-being in both mature and emerging regions.

Scope & Segmentation of the Animal Vaccines Market

  • Product Modalities: Inactivated vaccines, live attenuated vaccines, mRNA vaccines, recombinant vaccines, and subunit vaccines cover a broad technology spectrum, meeting diverse clinical and commercial demands.
  • Species: Solutions are developed for companion animals such as cats and dogs, as well as livestock including cattle, poultry, swine, and sheep, recognizing their varying epidemiological and economic impact.
  • Disease Targets: Vaccines address major bacterial threats (such as clostridial disease, E. coli, leptospirosis, pasteurella), significant viral diseases (including avian influenza, rabies, Newcastle disease virus, foot-and-mouth disease virus, bovine viral diarrhea, and porcine reproductive and respiratory syndrome virus), and key parasitic risks from both ectoparasites and endoparasites.
  • Routes of Administration: Delivery methods span injectable options—intramuscular, intravenous, subcutaneous—as well as oral formats, enabling flexibility in application based on species and field conditions.
  • Distribution Channels: Product reach is facilitated by online pharmacies, retail pharmacies, and veterinary clinics, each addressing distinct buyer preferences and regional channel strengths.
  • Key Regions: Major geographical segments include the Americas, Europe, Middle East & Africa, and Asia-Pacific, each offering unique regulatory, supply chain, and adoption dynamics.
  • Technology Trends: Key trends include adoption of platform technologies such as mRNA and recombinant systems, expansion of digital supply chain solutions supporting efficient distribution, and the integration of disease surveillance platforms for proactive response.

Key Takeaways for Animal Vaccine Industry Leaders

  • Accelerated development cycles are realized through advances in nucleic acid and recombinant antigen technologies, enabling more precise targeting across a diverse animal population.
  • Regulatory frameworks vary regionally, influencing both commercial timelines and required strategies. Successful cross-border launches often depend on early regulatory engagement and tailored market entry planning.
  • Regional manufacturing hubs and resilient supply chains help reduce operational risk, while improving time-to-market in varied geographies and supporting reliable access despite disruptions.
  • Alignment of R&D, manufacturing, and distribution functions is key to minimizing delays in adoption and to building resilience against shifting trade requirements and emerging infectious threats.
  • Advanced analytics and digital compliance tools are increasingly important for generating regulatory evidence and meeting payer standards, ultimately supporting stronger market acceptance and improved value communication.

Tariff Impact: Sourcing, Supply Chains, and Strategic Adjustments

Recent tariff changes and updated import classifications in 2025 have reshaped cost structures and operational decisions across the animal vaccines market. As a result, organizations are shifting toward regional sourcing, bolstering local manufacturing capabilities, and implementing robust contingency plans. These strategic adaptations include vendor diversification, renegotiation of supplier agreements, and investment in manufacturing redundancy to manage both cost volatility and supply continuity. The role of flexible logistics and tariff-aware commercial models continues to expand, requiring vigilant focus from executive teams to safeguard margins and ensure uninterrupted delivery to customers.

Animal Vaccines Market: Methodology & Data Sources

This market research leveraged a mixed-method approach, combining structured interviews with senior industry executives, veterinarians, regulatory experts, and supply chain operators with detailed technical literature and regulatory documentation reviews. Secondary triangulation and expert validation underpin the reliability and relevance of the findings for actionable decision support.

Why This Report Matters for Senior Animal Health Leaders

  • Empowers executive teams to align research platforms, manufacturing strategies, and commercialization pathways with fast-evolving market dynamics.
  • Offers clarity on adapting to regional regulatory, technology, and supply chain trends that directly affect profitability and operational agility.
  • Supports informed investment prioritization across products, geographies, and distribution channels, enabling growth strategies based on robust and current market evidence.

Conclusion

Meeting the demands of the evolving animal vaccines market requires coordinated innovation, agile regulatory response, and resilient operations. This report provides actionable guidance for senior leaders to transform technological advances into sustained value and competitive success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Animal Vaccines Market, by Product
8.1. Inactivated Vaccines
8.2. Live Attenuated Vaccines
8.3. mRNA Vaccines
8.4. Recombinant Vaccines
8.5. Subunit Vaccines
9. Animal Vaccines Market, by Animal Type
9.1. Companion Animals
9.1.1. Cats
9.1.2. Dogs
9.2. Livestock Animals
9.2.1. Cattle
9.2.2. Poultry
9.2.3. Sheep
9.2.4. Swine
10. Animal Vaccines Market, by Disease Type
10.1. Bacterial Infections
10.1.1. Clostridial
10.1.2. E. Coli
10.1.3. Leptospirosis
10.1.4. Pasteurella
10.2. Fungal Infections
10.3. Parasitic Infections
10.3.1. Ectoparasites
10.3.2. Endoparasites
10.4. Viral Infections
10.4.1. Avian Influenza Virus
10.4.2. Bovine Viral Diarrhea Virus (BVDV)
10.4.3. Foot-and-Mouth Disease Virus (FMDV)
10.4.4. Newcastle Disease Virus
10.4.5. Porcine Reproductive & Respiratory Syndrome Virus (PRRSV)
10.4.6. Rabies Virus
11. Animal Vaccines Market, by Route of Administration
11.1. Injectable Vaccines
11.1.1. Intramuscular (IM)
11.1.2. Intravenous (IV)
11.1.3. Subcutaneous (SC)
11.2. Oral Vaccines
12. Animal Vaccines Market, by Distribution Channel
12.1. Online Pharmacies
12.2. Retail Pharmacies
12.3. Veterinary Clinics
13. Animal Vaccines Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Animal Vaccines Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Animal Vaccines Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Animal Vaccines Market
17. China Animal Vaccines Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Biogénesis Bagó S.A.
18.6. BioVaxys Technology Corporation
18.7. Boehringer Ingelheim International GmbH
18.8. Brilliant Bio Pharma Private limited
18.9. Ceva Santé Animale
18.10. China Animal Husbandry Industry Co., Ltd.
18.11. Dalan Animal Health
18.12. Elanco Animal Health Inc.
18.13. Endovac Animal Health, LLC by Immvac Inc.
18.14. Hester Biosciences Limited
18.15. HIPRA, S.A.
18.16. Indian Immunologicals Limited
18.17. Kemin Industries, Inc.
18.18. Merck KGaA
18.19. Neogen Corporation
18.20. Phibro Animal Health Corporation
18.21. SAN Vet Holding GmbH
18.22. Sanofi S.A.
18.23. Seppic S.A.
18.24. Torigen Pharmaceuticals Inc.
18.25. Vaxxinova GmbH
18.26. VEROVACCiNES GmbH
18.27. Vetigenics, LLC
18.28. Vetoquinol SA
18.29. Virbac, Inc.
18.30. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MRNA VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MRNA VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SHEEP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SHEEP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CLOSTRIDIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CLOSTRIDIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CLOSTRIDIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LEPTOSPIROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LEPTOSPIROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LEPTOSPIROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PASTEURELLA, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PASTEURELLA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PASTEURELLA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FUNGAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FUNGAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ECTOPARASITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ECTOPARASITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ECTOPARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ENDOPARASITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ENDOPARASITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ENDOPARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA VIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA VIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA VIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANIMAL VACCINES MARKET SIZE, BY BOVINE VIRAL DIARRHEA VIRUS (BVDV), BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANIMAL VACCINES MARKET SIZE, BY BOVINE VIRAL DIARRHEA VIRUS (BVDV), BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANIMAL VACCINES MARKET SIZE, BY BOVINE VIRAL DIARRHEA VIRUS (BVDV), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT-AND-MOUTH DISEASE VIRUS (FMDV), BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT-AND-MOUTH DISEASE VIRUS (FMDV), BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT-AND-MOUTH DISEASE VIRUS (FMDV), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE VIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE VIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE VIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV), BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV), BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VIRUS (PRRSV), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES VIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES VIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES VIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INTRAMUSCULAR (IM), BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INTRAMUSCULAR (IM), BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INTRAMUSCULAR (IM), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INTRAVENOUS (IV), BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INTRAVENOUS (IV), BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INTRAVENOUS (IV), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBCUTANEOUS (SC), BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBCUTANEOUS (SC), BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBCUTANEOUS (SC), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ORAL VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ORAL VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS ANIMAL VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. EUROPE ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. EUROPE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 175. EUROPE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 179. EUROPE ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 184. EUROPE ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 199. AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 200. AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 201. AFRICA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 202. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 203. AFRICA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 204. AFRICA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 205. AFRICA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 206. AFRICA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 207. AFRICA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 208. AFRICA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 222. ASEAN ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 224. ASEAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 225. ASEAN ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 226. ASEAN ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 227. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 228. ASEAN ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 229. ASEAN ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 230. ASEAN ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 231. ASEAN ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 232. ASEAN ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 233. ASEAN ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. GCC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. GCC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 236. GCC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 237. GCC ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 238. GCC ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 239. GCC ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 240. GCC ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 241. GCC ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 242. GCC ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 243. GCC ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 244. GCC ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 245. GCC ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. BRICS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. BRICS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 260. BRICS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 261. BRICS ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 262. BRICS ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 263. BRICS ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 264. BRICS ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 265. BRICS ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 266. BRICS ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 267. BRICS ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 268. BRICS ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 269. BRICS ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. G7 ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. G7 ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 272. G7 ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 273. G7 ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 274. G7 ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 275. G7 ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 276. G7 ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 277. G7 ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 278. G7 ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 279. G7 ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 280. G7 ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 281. G7 ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 282. NATO ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. NATO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 284. NATO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 285. NATO ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 286. NATO ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 287. NATO ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 288. NATO ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 289. NATO ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 290. NATO ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 291. NATO ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 292. NATO ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 293. NATO ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 300. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 307. CHINA ANIMAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 308. CHINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 309. CHINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 310. CHINA ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 311. CHINA ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
TABLE 312. CHINA ANIMAL VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 313. CHINA ANIMAL VACCINES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 314. CHINA ANIMAL VACCINES MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 315. CHINA ANIMAL VACCINES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 316. CHINA ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 317. CHINA ANIMAL VACCINES MARKET SIZE, BY INJECTABLE VACCINES, 2018-2032 (USD MILLION)
TABLE 318. CHINA ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Animal Vaccines market report include:
  • Biogénesis Bagó S.A.
  • BioVaxys Technology Corporation
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private limited
  • Ceva Santé Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dalan Animal Health
  • Elanco Animal Health Inc.
  • Endovac Animal Health, LLC by Immvac Inc.
  • Hester Biosciences Limited
  • HIPRA, S.A.
  • Indian Immunologicals Limited
  • Kemin Industries, Inc.
  • Merck KGaA
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • SAN Vet Holding GmbH
  • Sanofi S.A.
  • Seppic S.A.
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetigenics, LLC
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.

Table Information